Women’s Sports Will Never Be The Same

The Supreme Court’s decision upholding state bans on transgender girls and women in female sports is not just a culture-war headline; it is a structural shift in how American law defines “sex,” fairness, and equal protection in education—and it deliberately leaves key scientific and constitutional questions unresolved.

At a Glance

  • The Court held 6–3 that Title IX permits sex-segregated teams and allows states to limit participation to sex assigned at birth, validating bans in at least 27 states.
  • The majority anchored its reasoning in the “ordinary meaning” of sex in 1972 and in early Title IX regulations, separating sports from broader LGBTQ employment protections under Bostock.
  • The Court declined to recognize transgender people as a protected class and asserted states’ interests in “safety and fairness” without engaging deeply with emerging sports science.
  • Dissenting justices and contemporary research highlight contested evidence on athletic advantage after hormone therapy, ensuring continued legal, scientific, and political conflict.

The Ruling: What the Court Actually Decided

In consolidated cases from Idaho and West Virginia, the Supreme Court upheld laws that require school and college sports teams to be designated based on sex assigned at birth and that bar transgender girls and women from competing on girls’ and women’s teams. Justice Brett Kavanaugh’s majority opinion concludes that these laws do not violate Title IX, the federal statute prohibiting sex discrimination in education, and do not offend the Equal Protection Clause of the Fourteenth Amendment.

The majority’s central move is interpretive rather than empirical. It treats “sex” in Title IX as referring to biological sex as understood in 1972, when the statute was enacted, and relies on early Department of Education regulations and the Javits Amendment to establish that sex-separated teams were contemplated and permitted from the start. In Kavanaugh’s framing, sports are a zero-sum domain: opening female categories to individuals classified as male at birth risks displacing cisgender girls and women from rosters and podiums. That risk, in the Court’s view, allows legislatures to draw hard lines at birth sex.

Importantly, the Court presents its holding as narrow. It emphasizes that states may restrict participation based on birth sex but are not compelled to do so; jurisdictions that currently allow transgender girls to play on girls’ teams—such as California or New York—remain free to maintain inclusive policies. At the same time, by declaring Idaho and West Virginia’s bans valid under both Title IX and equal protection, the Court effectively greenlights similar laws already in force across more than half the country.

Title IX, Equal Protection, and the Meaning of “Sex”

Title IX has long been both a civil rights engine and an administrative workhorse. On its face, it forbids discrimination “on the basis of sex” in any education program receiving federal funds. Since the 1970s, agencies and courts have read that language as supporting sex-segregated teams, so long as overall athletic opportunity for girls and women is equal. The current ruling leans heavily on this history. West Virginia’s solicitor general, and ultimately the majority, argue that “biological sex matters in athletics in ways both obvious and undeniable” and that separating teams by birth sex is therefore a legitimate, even foundational, feature of Title IX’s architecture.

Equal protection analysis is more delicate. Sex-based classifications ordinarily trigger heightened scrutiny; the state must show that they are substantially related to important governmental objectives, such as safety or fairness in competition. The majority accepts that premise but finds the bans justified, treating them as policies that apply uniformly to all individuals classified male at birth rather than as discrimination targeting transgender status. Crucially, the Court sidesteps the deeper question: whether transgender people constitute a quasi-suspect or suspect class entitled to more rigorous constitutional protection. It suggests the bans would survive even under heightened scrutiny but does not anchor that conclusion in detailed factual findings.

This posture makes the decision doctrinally conservative in two senses. First, it confines Bostock v. Clayton County—the 2020 case holding that firing employees for being gay or transgender violates Title VII—to the workplace, and refuses to extend its reasoning to educational athletics. Second, it declines to treat evolving scientific and social understandings of gender identity as relevant to the original meaning of “sex” in Title IX, reaffirming an originalist interpretive frame. For school systems and legislatures, that means “sex” in education law remains tethered to birth classification, unless Congress rewrites the statute.

Science, Safety, and Fairness: What the Evidence Shows and What It Doesn’t

The Court’s repeated invocation of “safety” and “fairness” rests more on intuition and traditional assumptions than on a robust evidentiary record. Kavanaugh references inherent physical differences and his own experience coaching girls’ basketball; state lawyers talk about zero-sum competition and risk of injury; but the opinion does not engage systematically with contemporary sports science. Neither does it cite comparative injury data or performance metrics from jurisdictions that include transgender athletes under medical criteria.

That omission is not because such research is nonexistent. A 2022 NIH-affiliated review, “Fairness for Transgender People in Sport,” concludes that testosterone-lowering treatment over multiple years may be sufficient to erase athletic advantage in at least some activities and finds limited evidence of persistent advantage in transgender women on standard regimens followed for several years. A fact-check drawing on work by researcher Joanna Harper reports that after two years of hormone therapy, transgender women’s performance largely equalized with cisgender women, even though differences remained after only one year. A 2024 study in the British Journal of Sports Medicine comparing strength, power, and aerobic capacity found transgender women performed worse than cisgender women in key measures such as countermovement jump height and normalized cardiovascular fitness.

These studies do not settle the debate—sample sizes are small, sports and levels of play vary, and the science is still developing—but they complicate any blanket assertion that “biological males” inevitably and permanently dominate competition against cisgender females. The American Psychological Association has gone further, stating that there is no evidence that allowing transgender students to play on teams matching their gender identity undermines fairness in scholastic sports. Justice Sotomayor’s dissent seizes on this point, criticizing the majority for resolving the legality of statewide bans without first remanding for more granular fact-finding about hormone therapy’s impact, sports-specific differences, and actual injury patterns.

On the safety side, the evidentiary landscape is thin. Neither the majority nor its supporters marshal data comparing injury rates in states with bans to those without, or in leagues that condition eligibility on medical criteria versus those that do not. Similarly, opponents of the bans have not yet produced comprehensive audits of injury patterns that directly rebut the safety rationale. Much of the discourse therefore relies on projected risk rather than observed harm—a gap that future research could fill but that presently leaves courts to lean on values and intuitions where data are incomplete.

The Broader Policy Landscape: States, Federations, and Executive Power

The Court’s ruling lands in a policy environment already transformed by state action and institutional rules. Since 2020, at least 27 states have enacted laws or regulations restricting transgender students from participating in school sports consistent with their gender identity, overwhelmingly focused on girls’ and women’s teams. At the college level, 18 states now limit transgender athletes’ participation, typically by anchoring eligibility to sex assigned at birth. The Williams Institute estimates that more than half of U.S. states have bans affecting transgender youth participation.

These state measures are part of a wider trend that includes the U.S. Olympic and Paralympic Committee’s move to bar transgender athletes from women’s events and executive-branch efforts to reinterpret Title IX to exclude gender identity from its protections. The Court’s decision effectively ratifies this approach: it signals that federal civil-rights law, as currently written, will not be used to invalidate state-level sex-at-birth eligibility rules in scholastic sports.

At the same time, the ruling does not mandate exclusion. States that have adopted more nuanced policies—tying eligibility to testosterone thresholds, duration of hormone therapy, or individualized medical assessments—remain free to continue those regimes. Internationally, the IOC’s 2016 policy allows transgender women to compete in female categories if they declare their gender for at least four years and maintain testosterone below a specified threshold for twelve months. Many scholars argue that these frameworks, while imperfect, are more closely aligned with available evidence than absolute bans anchored solely in birth classification.

Where Disagreement Truly Lies—and What Comes Next

The core legal disagreement is not over whether physical differences exist between average male and female bodies; few serious participants contest that. It is over how those differences should be legally operationalized in an educational setting that is both competitive and developmental, and over whether transgender identity should be recognized as a protected characteristic that constrains how states may regulate access to female categories.

Supporters of the bans emphasize the trajectory of women’s sports since Title IX and worry that opening female categories to anyone who identifies as a woman, regardless of birth sex or medical transition, could erode competitive opportunities for cisgender girls and women. They prefer bright-line rules, fearing that eligibility regimes based on hormone levels or case-by-case assessments invite litigation, inconsistency, and perceived unfairness. The Supreme Court’s majority shares that orientation, privileging administrability and historical meaning over evolving science.

Civil rights advocates and many medical organizations argue instead that blanket bans are both overbroad and unnecessary. They point to research showing substantial performance convergence after prolonged hormone therapy, the small number of transgender athletes actually competing in women’s scholastic sports, and the psychological and social harms of exclusion. For them, the central question is not just fairness in competition but equal dignity and access to the educational benefits of sport.

Because the Court declined to resolve whether transgender people are a protected class and because the underlying empirical record remains incomplete, litigation will continue. Future cases are likely to probe narrower policies—for example, bans limited to elite competition, or eligibility rules keyed to specific performance metrics—and to introduce more extensive expert testimony. Parallel work in public health and sports science, including longitudinal studies comparing states with and without bans, will be critical to grounding those disputes in evidence rather than projections.

For now, the Supreme Court has drawn a clear doctrinal line: in American school sports, “sex” under Title IX means birth sex, and states may enforce that definition to exclude transgender girls and women from female categories in the name of safety and fairness. Whether legislatures, institutions, and future courts will refine that line in light of emerging science and changing social norms remains an open—and consequential—question.

Sources:

feedpress.me, politico.com, youtube.com, vpm.org, edweek.org, aclu.org, nytimes.com, cato.org, pmc.ncbi.nlm.nih.gov, bjsm.bmj.com, digitalcommons.oberlin.edu, facebook.com, sciencedirect.com, reddit.com, bestcolleges.com